Following the implementation of citrate anticoagulation for continuous renal replacement
therapy, we evaluate its first year of use and compare it to the previously used heparin, to …

Background: Continuous renal replacement therapy (CRRT) is commonly used in the care of
critically ill patients (Gabutti et al., 2002). Critical illness increases the likelihood to both …

Systemic anticoagulation in maintenance hemodialysis (HD) has historically been
considered necessary to maintain the extracorporeal circuit (ECC) and preserve dialysis …

BACKGROUND: The ongoing necessity for systemic heparinization is a well-known
disadvantage of continuous renal replacement therapies (CRRT), and alternative methods …

Heparin-free haemodialysis must be considered for all dialysis patients with a risk of
haemorrhage. This technique is associated with increased danger of system coagulation …

Regional citrate anticoagulation for continuous renal replac... : Current Opinion in Critical Care
Regional citrate anticoagulation for continuous renal replacement therapy : Current Opinion in …

Background Regional citrate anticoagulation (RCA) is being increasingly used during
continuous renal replacement therapy (CRRT) in intensive care units as an alternative to …

Background Anticoagulation of the continuous renal replacement therapy (CRRT) circuit is
an important technical aspect of this medical procedure. Most studies evaluating the efficacy …

Background. Treatment modalities of renal replacement therapy differ in their diffusive and
convective mass transfer characteristics. It was the goal of this study to clarify whether an …

Objective: The effectiveness of continuous renal replacement therapy (CRRT) increases
when unplanned circuit failure is prevented. Adequate anticoagulation is an important …